Cite
HARVARD Citation
Tyler, L. et al. (2022). MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Thoracic cancer. 13 (21), pp. 3032-3041. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tyler, L. et al. (2022). MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Thoracic cancer. 13 (21), pp. 3032-3041. [Online].